It’s understood that around 6,000 patients could benefit from this.
The Irish Patients Association today welcomes the agreement reached between the State and the Irish Pharmaceutical Healthcare Association for a four-year medicines deal, expected to be approved by the Government.
According to Chair of the Irish Patients Association, Stephen McMahon said "This agreement addresses an unconscionable two-tier system where private patients access new cancer treatments up to two years before public patients can access the same medicine through the HSE."
For cancer medicines, it would cut delays by 514 days from the current 694-day average.
The agreement appropriately balances patients' rights to equitable access and innovation with the State's responsibility to ensure cost-effectiveness within finite health budgets.
Approximately 32 new medicines are expected this year, covering treatments for cancer, diabetes, and heart disease.
It’s understood that around 6,000 patients could benefit from this.
High-Speed Broadband Delivered To Over 14,000 Premises In Kildare
Withdrawal Of Solicitor Services For Criminal Legal Aid Cases Enters It's Fifth Day
Petrol and Diesel Prices Ease After US-Iran Peace Framework
Push For Locals In Kildare-Newbridge MD To Access Grants For Septic Tanks
Kfm Obituary Notices
Major Electricity Outage In Rathangan
Urgent Recall Of Ready Meals In Kildare, Wicklow And Wexford
€12K Funding Secured For Athy Food Market
